Modified GRF (1-29) or D-Ala2-GHRH-(1-29) is a ghrelin that is an active end of the GHRH (1-44). In normal people standard amounts of growth hormone is stored in the pituitary gland. Substitution of amino acids in the sequence of this peptide tends to enhance the level of biological activity due to a steep fall in the metabolic clearance. A study performed by researchers confirms that synthetic peptides like these can be looked forward to for the treatment of GH deficiency. When used in standard amounts and at regular intervals of time, this peptide is able to exhibit its potential to the max. In a comparative study, this peptide was able to cover up for the shortcomings that were witnessed in the clinical trials of GHRH (1-44). Comparative studies call for bulk usage of peptides that can be bought for a low-end price through the website of Pinnacle peptides Substitution of amino acids in this modified peptide enhances the property of aqueous stability which therefore saves the peptide molecules from the biological inactivation that may be triggered by body's enzymes. This attribute can assure the long-lasting activity of the peptide after its administration. Cleavage of some amino acids from the original peptide contributed the plasma stability attribute of the peptides too. Release of GHRH in an exogenous mode can be found supplementing the action of Modified GRF (1-29). The synergistic effect extended by the natural peptide tends to the tone of the active peptide up for an extended time in the body. The prime vantage of this peptide was discussed in a recent research review. This synthetic peptide boosts the release of natural hormones and at times even mimics the pattern of their release. Use of this peptide in research studies rules out the occurrence of any of the side effects that are encountered in the regular GH therapy. By boosting the release of growth hormone in diseased patients as well as normal subjects, this peptide helps in the sustenance of healthiness state in the elderly people. Surveys suggest that doses of Modified GRF 1-29 work in a more effectual manner if they are administered multiple times during the day instead of the single dose at night. The products we offer are intended for laboratory research use only. In purchasing any of these items, the customer acknowledges that there are risks involved with consumption or distribution of these products. These chemicals are NOT intended to use as food additives, drugs, cosmetics, household chemicals or other inappropriate applications. The listing of a material on this site does not constitute a license to its use in infringement of any patent. All of the products will be handled only by qualified and properly trained professionals. All customers represent and warrant that through their own review and study that they are fully aware and knowledgeable about the following: Government regulations regarding the use of and exposure to all products. The health and safety hazards associated with the handling of the products they purchase. The necessity of adequately warning of the health and safety hazards associated with any products. Pinnacle Peptides and pinnaclepeptides.com reserves the right to limit and/or deny sales of products to any unqualified individuals if we have reason to believe that misuse will occur.